Visipaque 320 MG/ML infus BTL 150ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQV1W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,589
Award facts
- Contract value 100% obligated
- $7,589.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,589.05 delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Visipaque 320 mg/ml infusion bottles (150ml). This is a firm fixed-price contract with an ultimate completion date of January 23, 2026, and represents a non-set-aside award issued under competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of medications, vaccines, and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The company maintains significant contracting relationships with the Defense Logistics Agency and other federal agencies, demonstrating consistent capability to fulfill government requirements for pharmaceutical products across multiple therapeutic domains. This specific delivery order for Visipaque, a contrast medium used in medical imaging procedures, exemplifies the company's role in supporting the medical supply needs of the Department of Defense and its healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQV1W?
SPE2DR26FQV1W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FQV1W worth?
The government has obligated $7,589 on SPE2DR26FQV1W.
Is contract SPE2DR26FQV1W an order under another contract?
Yes. SPE2DR26FQV1W is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV1W competed?
The extent of competition for SPE2DR26FQV1W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award